Colin Lightfoot

B.Sc. Biomedical Science, M.Sc. Infection and Immunity

Colin graduated from the University of Chester with a B.Sc. in Biomedical Science in 2020. Since completing his undergraduate degree, he worked for NHS England as an Associate Practitioner, responsible for testing inpatients for COVID-19 on admission.

Recently Colin was a Study Assistant for Perfectus Biomed, where he grew cell lines and viruses for the testing of mainly commercial cleaning products. He recently completed an M.Sc. in Infection and Immunity at The University of Chester, where his main research focus was antibiotic resistance and the possibility of combatting this with bacteriophage therapy.

See less

Articles from Colin

Simulating SARS-CoV-2 transmission dynamics for reopening European universities

Researchers from Graz University of Technology modeled transmission dynamics in a European university.

18 Nov 2021

Evidence of significantly greater protection against COVID from BNT162b2 boosters

In a new study, researchers from several British institutes estimated the effectiveness of booster vaccination against symptomatic COVID-19 in adults aged 50 years and older.

18 Nov 2021

Toll-like receptor 2 - novel target for improved COVID-19 vaccines

In a new study, researchers from French and American institutes analyzed at a molecular level the interaction between SARS-CoV-2 E protein and human TLR2.

17 Nov 2021

Spread of COVID-19 and effectiveness of contact tracing in a university population

Researchers from the University of Bristol were able to investigate how social behaviors of a university population changed with social restrictions and then the effectiveness of contact tracing in such a setting.

16 Nov 2021

Impact of COVID-19 vaccination in the Norwegian population

Researchers quantified the general VE achieved in the population of Norway, with the realized mixture of vaccine types, current population characteristics, and epidemic trajectory and directly estimated VE across vaccine types and age groups.

16 Nov 2021

Targeted proteomics for detection of SARS-CoV-2 proteins in clinical samples

A team of researchers from various institutions within the Netherlands examined the use of targeted MS-based proteomics for the detection of SARS-CoV-2 in research and clinical samples.

16 Nov 2021

Pregnancy outcomes during the Jordanian COVID-19 national lockdown

A Jordanian study was conducted to investigate the effects of the COVID-19 national lockdown on stillbirth, neonatal-perinatal mortality, preterm birth, and birth weight.

16 Nov 2021

How safe is it to travel on public transport amid COVID-19?

The authors extended this research by proposing a time-varying weighted Public Transportation Encounter Network that modeled the COVID-19 infectious process observed on public transport.

12 Nov 2021

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

12 Nov 2021

Phage-like particle system provides a platform for quick and easy vaccine generation

In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.

11 Nov 2021